{'fraction_non_alphanumeric': 0.026755852842809364, 'fraction_numerical': 0.0, 'mean_word_length': 5.801136363636363, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Mechanism of the cardiotonic effect of alpha-adrenoblockade by phentolamine].

In canine experiments with recording intraventricular pressure and its first derivative, with electromagnetic flowmetry and thermodilution it has been demonstrated that controlled Phentolamine-induced alpha-adrenergic block results in an increase of the cardiac output, heart rate, myocardial contractility index, and, at the same time, in a reduction of the total vascular resistance, arterial pressure, intraventricular pressure and heart work. The beneficial chronotropic effect of Phentolamine was shown not to depend on its suggested "central" action, to be not determined by reflex stimulation of the cardiac activity due to systemic hypotension, but to be brought about by a block of the myocardial alpha-adrenergic receptors and a moderate activation of beta-adrenergic receptors. The concept of the untoward chronotropic effects being mediated by myocardial alpha-adrenoreceptors is being substantiated. The mechanism of the beneficial inotropic effect of Phentolamine may be based on the stimulation of beta-receptors, concomitant tachycardia, and, probably, the effect of the "centrai" action of the drug.